Profit by knowlytics
Uncover the latest corporate headlines, economic policies, macro-level market updates, and industry developments shaping Indian and global markets on FinSiddhi.
Zoya Akhtar confirmed ‘Zindagi Na Milegi Dobara 2’ is in development with Reema Kagti, though its future remains uncertain until the right story emerges. A 2025 ad reignited fan buzz. Zoya also dismissed criticism about her films focusing on privileged characters, defending her creative freedom to tell varied stories.
Throughout LeBron James’ illustrious basketball journey, Savannah James has been his unwavering pillar of support. While he dedicated himself to games and practices, she created a nurturing family environment and pursued her own career and philanthropic efforts in Akron. Her steadfast presence during both triumphs and challenges has been instrumental in nurturing LeBron’s successes and…
Jana Nayagan, the much-anticipated final film of Vijay, is set to premiere on Zee5 starting August 21. This political action drama has garnered a varied reception but has enjoyed strong box office success. Despite facing numerous obstacles prior to its release, the film achieved impressive global earnings. Fans can now enjoy Vijay’s poignant farewell from…
The Dallas Cowboys have welcomed veteran pass rusher Von Miller to strengthen their defensive lineup. With nine sacks from last season, Miller’s extensive experience promises to enhance the team’s ability to pressure opposing quarterbacks in critical moments. This move not only fortifies the Cowboys’ pass rush but also allows younger edge rushers the opportunity to…
The Congress alleges the MMDR Amendment Bill threatens Odisha’s fiscal autonomy and mineral rights, and has sought an all-party meeting and a special Assembly session
ONGC has successfully obtained approval from the US Treasury, allowing it to further extend its oil operations in Venezuela. The newly acquired license significantly reduces sanctions-related barriers, paving the way for increased investments and production capabilities. With this development, ONGC can explore new contracts and possibly take over projects from PDVSA.
EyePoint’s experimental drug Duravyu failed a late-stage trial for a serious eye disease. The company’s shares dropped significantly after the disappointing trial results were announced. This failure impacts EyePoint’s goal to compete with Regeneron’s successful Eylea treatment. Analysts suggest investors will await further study confirmation for the drug’s viability. EyePoint plans a new trial and…
‘Trump suffering delusions’: Iran military denies direct backchannel talks with US
Trump’s foreign policy: Strongmen on speed dial, allies and partners on notice
Sebi warned investors against relying on live trading strategies and real-time stock tips shared on social media, saying such sessions may involve unregistered advisory services. The regulator urged investors to avoid such advice and deal only with Sebi-registered intermediaries.